Excessive daytime somnolence associated with Parkinson’s disease

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Excessive daytime sleepiness (EDS) occurs in up to 50 % of patients with Parkinson’s disease (PD) and is characterized by an inability to maintain full alertness in the daytime and undesirable lapses into sleep. Often overshadowed by the motor symptoms of PD, EDS can contribute to home and automobile accidents and have a negative impact on mood and overall quality of life. Sleep disturbances and EDS can result from the medications used to treat PD, degeneration of neuronal systems involved in the control of the sleep–wake system that occurs as part of the PD disease process, and comorbid conditions including specific sleep disorders and depression. The treatment of EDS in the PD patient requires careful evaluation of the multiple contributing causes and instituting recommendations that can consist of sleep hygiene and behavioral changes, alterations in the dosing and timing of PD medications, treatment of comorbid disorders, and the use of medications that affect nocturnal sleep quality and daytime alertness.

Original languageEnglish (US)
Title of host publicationDisorders of Sleep and Circadian Rhythms in Parkinson's Disease
PublisherSpringer-Verlag Vienna
Pages107-116
Number of pages10
ISBN (Print)9783709116319, 9783709116302
DOIs
StatePublished - Jan 1 2015

Fingerprint

Parkinson Disease
Sleep
Home Accidents
Automobiles
Quality of Life
Depression
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Battista, J., Monderer, R., & Thorpy, M. J. (2015). Excessive daytime somnolence associated with Parkinson’s disease. In Disorders of Sleep and Circadian Rhythms in Parkinson's Disease (pp. 107-116). Springer-Verlag Vienna. https://doi.org/10.1007/978-3-7091-1631-9_8

Excessive daytime somnolence associated with Parkinson’s disease. / Battista, James; Monderer, Renee; Thorpy, Michael J.

Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer-Verlag Vienna, 2015. p. 107-116.

Research output: Chapter in Book/Report/Conference proceedingChapter

Battista, J, Monderer, R & Thorpy, MJ 2015, Excessive daytime somnolence associated with Parkinson’s disease. in Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer-Verlag Vienna, pp. 107-116. https://doi.org/10.1007/978-3-7091-1631-9_8
Battista J, Monderer R, Thorpy MJ. Excessive daytime somnolence associated with Parkinson’s disease. In Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer-Verlag Vienna. 2015. p. 107-116 https://doi.org/10.1007/978-3-7091-1631-9_8
Battista, James ; Monderer, Renee ; Thorpy, Michael J. / Excessive daytime somnolence associated with Parkinson’s disease. Disorders of Sleep and Circadian Rhythms in Parkinson's Disease. Springer-Verlag Vienna, 2015. pp. 107-116
@inbook{7bcc8b512db44fd0bf824c2a7a808233,
title = "Excessive daytime somnolence associated with Parkinson’s disease",
abstract = "Excessive daytime sleepiness (EDS) occurs in up to 50 {\%} of patients with Parkinson’s disease (PD) and is characterized by an inability to maintain full alertness in the daytime and undesirable lapses into sleep. Often overshadowed by the motor symptoms of PD, EDS can contribute to home and automobile accidents and have a negative impact on mood and overall quality of life. Sleep disturbances and EDS can result from the medications used to treat PD, degeneration of neuronal systems involved in the control of the sleep–wake system that occurs as part of the PD disease process, and comorbid conditions including specific sleep disorders and depression. The treatment of EDS in the PD patient requires careful evaluation of the multiple contributing causes and instituting recommendations that can consist of sleep hygiene and behavioral changes, alterations in the dosing and timing of PD medications, treatment of comorbid disorders, and the use of medications that affect nocturnal sleep quality and daytime alertness.",
author = "James Battista and Renee Monderer and Thorpy, {Michael J.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-7091-1631-9_8",
language = "English (US)",
isbn = "9783709116319",
pages = "107--116",
booktitle = "Disorders of Sleep and Circadian Rhythms in Parkinson's Disease",
publisher = "Springer-Verlag Vienna",

}

TY - CHAP

T1 - Excessive daytime somnolence associated with Parkinson’s disease

AU - Battista, James

AU - Monderer, Renee

AU - Thorpy, Michael J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Excessive daytime sleepiness (EDS) occurs in up to 50 % of patients with Parkinson’s disease (PD) and is characterized by an inability to maintain full alertness in the daytime and undesirable lapses into sleep. Often overshadowed by the motor symptoms of PD, EDS can contribute to home and automobile accidents and have a negative impact on mood and overall quality of life. Sleep disturbances and EDS can result from the medications used to treat PD, degeneration of neuronal systems involved in the control of the sleep–wake system that occurs as part of the PD disease process, and comorbid conditions including specific sleep disorders and depression. The treatment of EDS in the PD patient requires careful evaluation of the multiple contributing causes and instituting recommendations that can consist of sleep hygiene and behavioral changes, alterations in the dosing and timing of PD medications, treatment of comorbid disorders, and the use of medications that affect nocturnal sleep quality and daytime alertness.

AB - Excessive daytime sleepiness (EDS) occurs in up to 50 % of patients with Parkinson’s disease (PD) and is characterized by an inability to maintain full alertness in the daytime and undesirable lapses into sleep. Often overshadowed by the motor symptoms of PD, EDS can contribute to home and automobile accidents and have a negative impact on mood and overall quality of life. Sleep disturbances and EDS can result from the medications used to treat PD, degeneration of neuronal systems involved in the control of the sleep–wake system that occurs as part of the PD disease process, and comorbid conditions including specific sleep disorders and depression. The treatment of EDS in the PD patient requires careful evaluation of the multiple contributing causes and instituting recommendations that can consist of sleep hygiene and behavioral changes, alterations in the dosing and timing of PD medications, treatment of comorbid disorders, and the use of medications that affect nocturnal sleep quality and daytime alertness.

UR - http://www.scopus.com/inward/record.url?scp=84948969586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948969586&partnerID=8YFLogxK

U2 - 10.1007/978-3-7091-1631-9_8

DO - 10.1007/978-3-7091-1631-9_8

M3 - Chapter

AN - SCOPUS:84948969586

SN - 9783709116319

SN - 9783709116302

SP - 107

EP - 116

BT - Disorders of Sleep and Circadian Rhythms in Parkinson's Disease

PB - Springer-Verlag Vienna

ER -